Docmorris Ag Stock Beta

DOCM Stock   5.60  0.01  0.18%   
As of the 2nd of February, DocMorris shows the Semi Deviation of 3.38, mean deviation of 2.66, and Downside Deviation of 3.55. DocMorris AG technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DocMorris AG mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if DocMorris AG is priced favorably, providing market reflects its regular price of 5.6 per share.

DocMorris Total Revenue

1.08 Billion

DocMorris' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DocMorris' valuation are provided below:
Gross Profit
230.3 M
Profit Margin
(0.11)
Market Capitalization
272.2 M
Enterprise Value Revenue
0.3554
Revenue
1.1 B
There are over one hundred nineteen available fundamental signals for DocMorris AG, which can be analyzed over time and compared to other ratios. All traders should should verify DocMorris' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Enterprise Value is likely to climb to about 488.3 M in 2026, whereas Market Cap is likely to drop slightly above 257.4 M in 2026. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

DocMorris Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for DocMorris is extremely important. It helps to project a fair market value of DocMorris Stock properly, considering its historical fundamentals such as Beta. Since DocMorris' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DocMorris' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DocMorris' interrelated accounts and indicators.
It's important to distinguish between DocMorris' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocMorris should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocMorris' market price signifies the transaction level at which participants voluntarily complete trades.

DocMorris 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DocMorris' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DocMorris.
0.00
11/04/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/02/2026
0.00
If you would invest  0.00  in DocMorris on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding DocMorris AG or generate 0.0% return on investment in DocMorris over 90 days. DocMorris is related to or competes with IVF Hartmann, Coltene Holding, Newron Pharmaceuticals, Santhera Pharmaceuticals, Molecular Partners, Ascom Holding, and S H. DocMorris is entity of Switzerland. It is traded as Stock on SW exchange. More

DocMorris Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DocMorris' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DocMorris AG upside and downside potential and time the market with a certain degree of confidence.

DocMorris Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DocMorris' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DocMorris' standard deviation. In reality, there are many statistical measures that can use DocMorris historical prices to predict the future DocMorris' volatility.
Hype
Prediction
LowEstimatedHigh
1.685.609.52
Details
Intrinsic
Valuation
LowRealHigh
0.834.758.67
Details
Naive
Forecast
LowNextHigh
1.365.289.20
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.66-0.58-0.48
Details

DocMorris February 2, 2026 Technical Indicators

DocMorris AG Backtested Returns

DocMorris appears to be relatively risky, given 3 months investment horizon. DocMorris AG secures Sharpe Ratio (or Efficiency) of 0.0553, which denotes the company had a 0.0553 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for DocMorris AG, which you can use to evaluate the volatility of the firm. Please utilize DocMorris' Downside Deviation of 3.55, semi deviation of 3.38, and Mean Deviation of 2.66 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DocMorris holds a performance score of 4. The firm shows a Beta (market volatility) of 1.08, which means a somewhat significant risk relative to the market. DocMorris returns are very sensitive to returns on the market. As the market goes up or down, DocMorris is expected to follow. Please check DocMorris' downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether DocMorris' price patterns will revert.

Auto-correlation

    
  -0.2  

Insignificant reverse predictability

DocMorris AG has insignificant reverse predictability. Overlapping area represents the amount of predictability between DocMorris time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DocMorris AG price movement. The serial correlation of -0.2 indicates that over 20.0% of current DocMorris price fluctuation can be explain by its past prices.
Correlation Coefficient-0.2
Spearman Rank Test-0.09
Residual Average0.0
Price Variance0.11
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, DocMorris AG has a Beta of 1.798. This is much higher than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The beta for all Switzerland stocks is notably lower than that of the firm.

DocMorris Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocMorris' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocMorris could also be used in its relative valuation, which is a method of valuing DocMorris by comparing valuation metrics of similar companies.
DocMorris is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DocMorris will likely underperform.

DocMorris Fundamentals

About DocMorris Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DocMorris AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocMorris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocMorris AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.